Camurus
CAMX | ST
Overview
Corporate Details
- ISIN(s):
- SE0007692850 (+2 more)
- LEI:
- 5493003S6Z6VI7WYFQ06
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.camurus.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of opioid dependence and chronic pain, rare diseases, oncology and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-18 08:00 |
Earnings Release
Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic live…
|
English | 168.7 KB | |
| 2025-06-18 08:00 |
Earnings Release
Camurus studie POSITANO visar behandlingseffekt av CAM2029 i patienter med poly…
|
Swedish | 167.8 KB | |
| 2025-06-03 19:45 |
Regulatory News Service
Camurus and Lilly ingår samarbets- och licensavtal avseende långtidsverkande in…
|
Swedish | 169.9 KB | |
| 2025-06-03 19:45 |
Regulatory News Service
Camurus and Lilly enter collaboration and license agreement for long-acting Flu…
|
English | 171.3 KB | |
| 2025-05-27 21:30 |
Declaration of Voting Results & Voting Rights Announcements
Camurus styrelse utnyttjar återköpsbemyndigande för säkerställande av bolagets …
|
Swedish | 135.3 KB | |
| 2025-05-27 21:30 |
Transaction in Own Shares
Camurus’ Board of Directors exercises authorization for repurchase of shares fo…
|
English | 141.2 KB | |
| 2025-05-27 18:50 |
Declaration of Voting Results & Voting Rights Announcements
Resolutions at the annual general meeting 2025 in Camurus
|
English | 155.3 KB | |
| 2025-05-27 18:50 |
Declaration of Voting Results & Voting Rights Announcements
Beslut vid Camurus årsstämma 2025
|
Swedish | 152.1 KB | |
| 2025-05-15 07:00 |
Earnings Release
|
Swedish | 695.2 KB | |
| 2025-05-15 07:00 |
Earnings Release
|
English | 683.0 KB | |
| 2025-05-14 08:00 |
Board/Management Change
Camurus appoints Anders Vadsholt as Chief Financial Officer
|
English | 142.8 KB | |
| 2025-05-14 08:00 |
Board/Management Change
Anders Vadsholt utsedd till Chief Financial Officer på Camurus
|
Swedish | 140.1 KB | |
| 2025-04-30 10:00 |
Annual Report (ESEF)
|
Swedish | 27.4 MB | |
| 2025-04-25 16:00 |
Regulatory News Service
CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
|
English | 161.5 KB | |
| 2025-04-25 16:00 |
Regulatory News Service
CHMP rekommenderar godkännande av Oczyesa® för behandling av akromegali i EU
|
Swedish | 159.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-17 | Torsten Malmström | Other | Sell | 10,000 | 6,806,400.00 SEK |
| 2024-06-17 | Jon Uguzne Garay Alonso | Other | Other | 33,750 | N/A |
| 2024-05-14 | Torsten Malmström | Other | Sell | 1,495 | 844,675.00 SEK |
| 2024-05-10 | Annette Mattsson | Other | Sell | 1,000 | 550,000.00 SEK |
| 2023-12-15 | Annette Mattsson | Other | Other | 1,000 | 169,500.00 SEK |
| 2023-09-18 | Annette Mattsson | Other | Sell | 1,000 | 294,600.00 SEK |
| 2023-09-06 | Maria Lundqvist | Other | Other | 381 | N/A |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 77 | 22,610.28 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Sell | 58 | 17,032.86 SEK |
| 2023-08-23 | Maria Lundqvist | Other | Other | 77 | 13,051.50 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |